Hermeking H, Funk J O, Reichert M, Ellwart J W, Eick D
Institut für Klinische Molekularbiologie und Tumorgenetik, GSF-Forschungszentrum für Umwelt und Gesundheit, München, Germany.
Oncogene. 1995 Oct 5;11(7):1409-15.
The tumor-suppressor p53 inhibits cell cycle progression by direct transactivation of the p21WAF1/CIP1/SDI1 gene, which encodes a universal inhibitor of cyclin dependent kinases (cdk). The proto-oncogene product c-Myc induces cell cycle progression and, in the absence of survival factors, apoptosis. However, a direct link between the cell cycle machinery and c-Myc has not yet been established. We show that c-Myc has not yet been established. We show that c-Myc abrogates a p53-induced G1-arrest without elevating the expression of cdks or cyclins involved in the G1/S-transition. Instead, the results suggest that c-Myc interferes with the inhibitory action of p21 on cdk/cyclin-complexes by inducing a heat-labile inhibitor of p21. The inactivation of p21 and related cdk-inhibitors may explain several of the oncogenic actions of c-Myc, including the induction of proliferation, immortalisation and the inhibition of differentiation. Modulation of cdk activity by the induction of an inhibitor of cdk-inhibitors represents a novel mechanism of cell cycle regulation in mammalian cells.
肿瘤抑制因子p53通过直接反式激活p21WAF1/CIP1/SDI1基因来抑制细胞周期进程,该基因编码一种细胞周期蛋白依赖性激酶(cdk)的通用抑制剂。原癌基因产物c-Myc可诱导细胞周期进程,且在缺乏生存因子时可诱导细胞凋亡。然而,细胞周期机制与c-Myc之间的直接联系尚未确立。我们发现c-Myc消除了p53诱导的G1期阻滞,却未提高参与G1/S转换的cdk或细胞周期蛋白的表达。相反,结果表明c-Myc通过诱导一种对热不稳定的p21抑制剂来干扰p21对cdk/细胞周期蛋白复合物的抑制作用。p21及相关cdk抑制剂的失活可能解释了c-Myc的几种致癌作用,包括诱导增殖、永生化和抑制分化。通过诱导cdk抑制剂的抑制剂来调节cdk活性代表了哺乳动物细胞中一种新的细胞周期调控机制。